Hepatitis C cases dropped in the US. Health officials unsure if it’s a blip or trend
“NEW YORK — New U.S. hepatitis C infections dropped slightly in 2022, a surprising improvement after more than a decade of steady increases, federal health officials said Wednesday.”
READ THE REPORT Hepatitis C Surveillance 2022
Telehealth Improves Hepatitis C Treatment in Patients With Opioid Use Disorder
“Facilitated telemedicine integrated into an opioid treatment program led to better hepatitis C virus (HCV) cure rates compared with usual referral-based care, a randomized clinical trial showed. In an intention-to-treat analysis, sustained virologic response (SVR) rates were substantially higher for those who had facilitated telemedicine compared with those referred for usual care (90.3% vs 39.4%), with a nearly threefold higher odds of achieving a cure (OR 2.9, 95% CI 2.0-3.5, P<0.001), Andrew Talal, MD, MPH, of the University at Buffalo, and colleagues reported in JAMA.”
Judge rejects group’s attempt to open safe injection site in Philadelphia
“A federal judge in Philadelphia rejected a nonprofit’s attempt to open a safe drug-injection site in the city. Safehouse, the organization that seeks to provide overdose prevention services, said the threat of prosecution by the Department of Justice over potentially violating drug laws is hindering its religious rights as a group.”
